Research Grant
[Cite as https://purl.org/au-research/grants/nhmrc/1138812]Researchers: A/Pr Ana Traven (Principal investigator)
Brief description Fungal infections represent a major health burden, with loss of lives that parallels malaria. Only a handful of antifungal therapeutics is available, and mortality remains very high (30% or more). By using molecular biology approaches and animal infection models, this project aims to characterize a new class of promising antifungal drug targets in the major human fungal pathogen Candida albicans. The outcomes will provide the knowledge foundation for future antifungal drug discovery.
Funding Amount $AUD 710,393.19
Funding Scheme Project Grants
Notes Standard Project Grant
- nhmrc : 1138812
- PURL : https://purl.org/au-research/grants/nhmrc/1138812